These authors contributed equally to this work.
Steatohepatitis/Metabolic Liver Disease
FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis
Article first published online: 27 MAR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 5, pages 1779–1790, May 2014
How to Cite
Wang, C., Chi, Y., Li, J., Miao, Y., Li, S., Su, W., Jia, S., Chen, Z., Du, S., Zhang, X., Zhou, Y., Wu, W., Zhu, M., Wang, Z., Yang, H., Xu, G., Wang, S., Yang, J. and Guan, Y. (2014), FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. Hepatology, 59: 1779–1790. doi: 10.1002/hep.26945
Potential conflict of interest: Nothing to report.
Supported by grants from the Ministry of Science and Technology (2012CB517504/2009CB941603/2010CB912503) and the Natural Science Foundation (81170791/2011ZX09102/81322011). Support for this project was also provided by the “111 Project” of China and a grant from Beijing Natural Science Foundation (7122107).
- Issue published online: 23 APR 2014
- Article first published online: 27 MAR 2014
- Accepted manuscript online: 23 NOV 2013 03:28AM EST
- Manuscript Accepted: 18 NOV 2013
- Manuscript Received: 29 MAY 2013